ENTRY       D11798                      Drug
NAME        Cipaglucosidase alfa (USAN);
            Cipaglucosidase alfa (genetical recombination) (JAN);
            Cipaglucosidase alfa-atga;
            Pombiliti (TN)
PRODUCT     POMBILITI (AMICUS THERAPEUTICS US)
FORMULA     C4489H6817N1197O1298S32
EXACT_MASS  99284.5283
MOL_WEIGHT  99346.4804
SEQUENCE    QQGASRPGPR DAQAHPGRPR AVPTQCDVPP NSRFDCAPDK AITQEQCEAR GCCYIPAKQG
            LQGAQMGQPW CFFPPSYPSY KLENLSSSEM GYTATLTRTT PTFFPKDILT LRLDVMMETE
            NRLHFTIKDP ANRRYEVPLE TPHVHSRAPS PLYSVEFSEE PFGVIVRRQL DGRVLLNTTV
            APLFFADQFL QLSTSLPSQY ITGLAEHLSP LMLSTSWTRI TLWNRDLAPT PGANLYGSHP
            FYLALEDGGS AHGVFLLNSN AMDVVLQPSP ALSWRSTGGI LDVYIFLGPE PKSVVQQYLD
            VVGYPFMPPY WGLGFHLCRW GYSSTAITRQ VVENMTRAHF PLDVQWNDLD YMDSRRDFTF
            NKDGFRDFPA MVQELHQGGR RYMMIVDPAI SSSGPAGSYR PYDEGLRRGV FITNETGQPL
            IGKVWPGSTA FPDFTNPTAL AWWEDMVAEF HDQVPFDGMW IDMNEPSNFI RGSEDGCPNN
            ELENPPYVPG VVGGTLQAAT ICASSHQFLS THYNLHNLYG LTEAIASHRA LVKARGTRPF
            VISRSTFAGH GRYAGHWTGD VWSSWEQLAS SVPEILQFNL LGVPLVGADV CGFLGNTSEE
            LCVRWTQLGA FYPFMRNHNS LLSLPQEPYS FSEPAQQAMR KALTLRYALL PHLYTLFHQA
            HVAGETVARP LFLEFPKDSS TWTVDHQLLW GEALLITPVL QAGKAEVTGY FPLGTWYDLQ
            TVPVEALGSL PPPPAAPREP AIHSEGQWVT LPAPLDTINV HLRAGYIIPL QGPGLTTTES
            RQQPMALAVA LTKGGEARGE LFWDDGESLE VLERGAYTQV IFLARNNTIV NELVRVTSEG
            AGLQLQKVTV LGVATAPQQV LSNGVPVSNF TYSPDTKVLD ICVSLLMGEQ FLVSWC
            (Disulfide bridge: 26-53, 36-52, 47-71, 477-502, 591-602)
  TYPE      Peptide
REMARK      ATC code: A16AB23
            Product: D11798<US>
EFFICACY    Enzyme replacement (alpha-glucosidase)
  DISEASE   Pompe disease [DS:H01940]
  TYPE      Enzyme replacement therapy product
COMMENT     Treatment of Pompe disease
TARGET      GAA* [HSA_VAR:2548v1] [HSA:2548] [KO:K12316]
  PATHWAY   hsa00052(2548)  Galactose metabolism
            hsa00500(2548)  Starch and sucrose metabolism
            hsa04142(2548)  Lysosome
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AB Enzymes
                 A16AB23 Cipaglucosidase alfa
                  D11798  Cipaglucosidase alfa (USAN) &lt;US&gt;
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Glycosidases
                GAA* [HSA_VAR:2548v1]
                 D11798  Cipaglucosidase alfa (USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11798
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11798
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D11798
DBLINKS     CAS: 2359727-71-0
            PubChem: 405226664
///
